Identification of Differentially Expressed Genes in Spinal Cord Injury

Andrew Chang, Shevanka Dias Abeyagunawardene, Xiaohang Zheng, Haiming Jin, Xian Wang, Jiake XuGenes 2025 · DOI

TL;DR

Spinal cord injury (SCI) is a devastating condition with limited treatment options, partly due to a poor understanding of its complex molecular underpinnings. This study used RNA sequencing to identify genes whose expression changes after SCI in rats, revealing a significant role for immune and autoimmune responses in the injury's progression and highlighting potential new therapeutic targets.

What Problem Does This Paper Address?

Spinal cord injury (SCI) is a major cause of disability, yet effective treatments remain elusive. A key reason for this is our incomplete understanding of the intricate molecular and cellular processes that occur after injury. While previous research has identified some genes involved in SCI, many studies have focused on individual markers, which may not capture the full complexity of the disease. Furthermore, there's a particular lack of understanding regarding genes that are downregulated after SCI, which could be crucial for recovery. This paper aims to provide a comprehensive view of the gene expression landscape following SCI by identifying differentially expressed genes (DEGs) at different time points post-injury and exploring the biological pathways they are involved in.

Methods

The researchers employed a RNA-sequencing (RNA-seq) approach to analyze gene expression in rat spinal cord tissue at two key time points: 1 day post-injury (dpi) and 21 dpi. This allowed them to capture both the immediate and more sustained molecular changes.

Here's a breakdown of their methodology:

  • Sample Collection: Spinal cord tissue was collected from a rat SCI model (clip-compression at T9-T10 vertebral level) at 1 and 21 days post-injury, along with control samples.
  • RNA Extraction and Sequencing: Total RNA was extracted, and libraries were prepared for sequencing on an Illumina NovaSeq 6000 platform.
  • Data Pre-processing: Raw RNA-seq data underwent quality control, including log2 transformation and removal of low-expression genes.
  • Differential Gene Expression Analysis: Statistical analysis using the limma R package was performed to identify genes with significant changes in expression (log fold change > 1 and p < 0.05) between injured and control groups at both time points.
  • Functional Enrichment Analysis: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted using DAVID and GSEA tools to understand the biological processes, cellular components, and molecular functions associated with the identified DEGs.
  • Protein-Protein Interaction (PPI) Network Analysis: STRING database and Cytoscape software were used to visualize and analyze interactions among the DEGs, identifying key gene clusters and regulatory networks.

Datasets

The study utilized RNA-sequencing data generated from the spinal cord tissue of Sprague-Dawley rats subjected to a clip-compression model of spinal cord injury. Control samples were also collected. The dataset comprised nearly twenty thousand identified genes.

Key Insights and Ideas

  • Immune and Autoimmune Dominance: The most striking finding is the strong enrichment of immune and autoimmune-related pathways among the upregulated genes. This suggests that the body's own defense and regulatory systems play a significant, and potentially detrimental, role in the aftermath of SCI.
  • Myelin and Synapse Disruption: Conversely, downregulated genes were heavily associated with pathways related to myelin sheath maintenance and neuronal synapse function. This points to a breakdown in crucial components for nerve signal transmission and repair.
  • Sustained Molecular Changes: The study identified genes that were consistently upregulated or downregulated at both 1 and 21 dpi, indicating that these changes are not transient but rather represent a sustained molecular response to the injury.
  • Potential for Novel Therapeutics: By identifying specific genes and pathways involved in both the damaging inflammatory/autoimmune responses and the impaired regenerative processes, the study lays the groundwork for developing targeted therapeutic interventions.

Key Results

  • Differential Gene Expression: The analysis identified 595 differentially expressed genes (DEGs) when comparing injured to control groups across both time points. Of these, 399 genes were significantly upregulated, and 196 were significantly downregulated.
  • Top Upregulated Gene: CD68 was the most significantly upregulated gene at 21 dpi.
  • Top Downregulated Gene: MPZ (Myelin Protein Zero) was identified as the most downregulated gene.
  • Enriched Pathways (Upregulated): Key immune response pathways, including tumor necrosis factor (TNF) production, phagocytosis, complement cascades, and systemic lupus erythematosus (SLE)-associated pathways, were significantly enriched.
  • Enriched Pathways (Downregulated): Pathways related to the myelin sheath and neuronal synapse were enriched in the downregulated group.
  • Specific Genes of Interest: Genes like SCD, DHCR24, PRX, HHIP, and ZDHHC22 were highlighted as significantly downregulated and potentially important for recovery.
  • Autoimmune Markers: Upregulation of Fc-γ receptor genes (FCGR2B, FCGR2A) suggests potential autoimmune mechanisms at play.

Limitations and Future Work

  • Time Points: The study focused on 1 and 21 dpi. The authors acknowledge that gene expression is dynamic, and intermediate time points might reveal further transient changes. Future research could explore these intermediate stages.
  • Functional Validation: While the study identifies DEGs and enriched pathways, it primarily relies on bioinformatic analysis. The authors suggest that functional assays and protein-level analyses are needed to validate the functional significance of these findings.
  • Cell-Specific Analysis: The study analyzed total spinal cord tissue. Single-cell RNA sequencing is recommended to identify cell-specific gene expression changes and pinpoint the exact cell types driving these responses.
  • Therapeutic Validation: The identified DEGs and pathways are proposed as potential therapeutic targets. Future work should focus on validating these targets and developing interventions based on these findings.
  • Complex Immune Interactions: The interplay between immune and autoimmune responses in SCI is complex and warrants further investigation. The study suggests that SCI may not only involve immune dysfunction but also long-term autoimmune dysregulation.

Summary updated

Abstract

Our findings highlight complex immune and autoimmune responses that contribute to ongoing inflammation and tissue damage post-SCI, underscoring new avenues for therapeutic interventions targeting these molecular processes.
BibTeX
@inproceedings{chang2025identification,
  author = {Andrew Chang and Shevanka Dias Abeyagunawardene and Xiaohang Zheng and Haiming Jin and Xian Wang and Jiake Xu},
  title = {{Identification of Differentially Expressed Genes in Spinal Cord Injury}},
  booktitle = {Genes},
  year = {2025},
  doi = {10.3390/genes16050514},
}
Figure